• <em>MOXD1</em> is a lineage-specific gene and a tumor suppressor in neuroblastoma
• A Case of Olfactory Neuroblastoma Developing Bilateral Retropharyngeal Lymph Node Metastasis 14-years After Skull Base Surgery
• A mitochondria-related genes associated neuroblastoma signature - based on bulk and single-cell transcriptome sequencing data analysis, and experimental validation
• A novel APP splice variant-dependent marker system to precisely demarcate maturity in SH-SY5Y cell-derived neurons
• A Perspective on the CD47-SIRPA Axis in High-Risk Neuroblastoma
• Advancing presurgical non-invasive molecular subgroup prediction in medulloblastoma using artificial intelligence and MRI signatures
• An integrated single-cell RNA-seq map of human neuroblastoma tumors and preclinical models uncovers divergent mesenchymal-like gene expression programs
• Analyses of combined Merkel cell carcinomas with neuroblastic components suggests that loss of T antigen expression in Merkel cell carcinoma may result in cell cycle arrest and neuroblastic transdifferentiation
• Application of the FISH method and high-density SNP arrays to assess genetic changes in neuroblastoma-research by one institute
• Augmentation of tumor expression of HLA-DR, CXCL9, and CXCL10 may improve olfactory neuroblastoma immunotherapeutic responses
• Autophagic degradation of CDK4 is responsible for G0/G1 cell cycle arrest in NVP-BEZ235-treated neuroblastoma
• Beyond Clinical Trials: Understanding Neurotrophic Tropomyosin Receptor Kinase Inhibitor Challenges and Efficacy in Real-World Pediatric Oncology
• Cadaveric analysis of surgical techniques and working space for retroperitoneal tumors as model for improving resection of neuroblastoma
• CAR T-cell-mediated delivery of bispecific innate immune cell engagers for neuroblastoma
• CD11b maintains West Nile virus replication through modulation of immune response in human neuroblastoma cells
• Clinical analysis of endonasal endoscopic surgery in esthesioneuroblastoma
• Clinical significance of sarcopenia in children with neuroblastic tumors
• Clinically unfavorable transcriptome subtypes of non-WNT/non-SHH medulloblastomas are associated with a predominance in proliferating and progenitor-like cell subpopulations
• Clinicopathological characteristics of the CD8⁺ T lymphocytes infiltration and its mechanism in distinct molecular subtype of medulloblastoma
• Combined Germline and Mosaic SDHA Mutation Is Associated With a Multicancer Syndrome Including Neuroblastoma, Renal Cancer, and Multifocal GI Tumor
• Comprehensive analysis identifies ubiquitin ligase FBXO42 as a tumor-promoting factor in neuroblastoma
• Curcumin's membrane localization and disruptive effects on cellular processes - insights from neuroblastoma, leukemic cells, and Langmuir monolayers
• Current and Emerging Biomarkers: Impact on Risk Stratification for Neuroblastoma
• Deep learning models for predicting the survival of patients with medulloblastoma based on a surveillance, epidemiology, and end results analysis
• Developing targeted therapies for neuroblastoma by dissecting the effects of metabolic reprogramming on tumor microenvironments and progression
• Effect of Cannabis sativa L. extracts, phytocannabinoids and their acetylated derivates on the SHSY-5Y neuroblastoma cells' viability and caspases 3/7 activation
• Effect of Xanthohumol, a Bioactive Natural Compound from Hops, on Adenosine Pathway in Rat C6 Glioma and Human SH-SY5Y Neuroblastoma Cell Lines
• Effects and mechanisms of puerarin against neuroblastoma: insights from bioinformatics and in vitro experiments
• Endoscopy-assisted medial canthus incision for olfactory neuroblastoma: a case report
• Ewing sarcoma of the uterus: A case report
• Ewing sarcoma/primitive hepatic neuroectodermal tumor
• Exploring differentiation-dependent responses to 532 nm green laser photobiomodulation in SHSY5Y neuroblastoma cells
• Exploring the effects of three-finger toxins from Naja ashei venom on neuronal and immunological cancer cell membranes
• Exploring the Regulation of Cytochrome P450 in SH-SY5Y Cells: Implications for the Onset of Neurodegenerative Diseases
• Extracting Electronic Health Record Neuroblastoma Treatment Data With High Fidelity Using the REDCap Clinical Data Interoperability Services Module
• From Nicki Minaj to Neuroblastoma: What Rigorous Approaches to Rhythms and Radiomics Have in Common
• Genome-wide CRISPR-Cas9 knockout screens identify DNMT1 as a druggable dependency in sonic hedgehog medulloblastoma
• GSTO2 ameliorates human neuroblastoma cell apoptosis, inflammation, ferroptosis, and oxidative stress by upregulating GPX4 expression in intracerebral hemorrhage
• Human platelet lysate supports SH-SY5Y neuroblastoma cell proliferation and differentiation into a dopaminergic-like neuronal phenotype under xenogeneic-free culture conditions
• Identification and validation of miRNA-target genes network in pediatric brain tumors
• Identification of tumor rejection antigens and the immunologic landscape of medulloblastoma
• Impact of ALK inhibitors to potentiate ALK.CAR-T therapy in neuroblastoma
• Impact of pre-treatment extracellular volume fraction measured by computed tomography on response of primary lesion to preoperative chemotherapy in abdominal neuroblastoma
• In vivo cisplatin-resistant neuroblastoma metastatic model reveals tumour necrosis factor receptor superfamily member 4 (TNFRSF4) as an independent prognostic factor of survival in neuroblastoma
• Integrated re-analysis of transcriptomic and proteomic datasets reveals potential mechanisms for Zika viral-based oncolytic therapy in neuroblastoma
• Irinotecan and temozolomide in combination with dasatinib and rapamycin versus irinotecan and temozolomide for patients with relapsed or refractory neuroblastoma (RIST-rNB-2011): a multicentre, open-label, randomised, controlled, phase 2 trial
• Leading medulloblastoma to a differentiation end
• Letter to the editor "Neurosurgical short-term outcomes for pediatric medulloblastoma patients and molecular correlations: a 10-year single-centre observation cohort study"
• Long Non-Coding RNAs in Neuroblastoma: Pathogenesis, Biomarkers and Therapeutic Targets
• Long-term effects of local radiotherapy on growth and vertebral features in children with high-risk neuroblastoma
• Loss of Chromosome Y in Neuroblastoma Is Associated With High-Risk Disease, 11q-Deletion, and Telomere Maintenance
• Lysophosphatidic Acid Stimulates Mitogenic Activity and Signaling in Human Neuroblastoma Cells through a Crosstalk with Anaplastic Lymphoma Kinase
• Maintaining Survival While Improving Quality of Life: An Advanced Practitioner-Led Pilot Feasibility Study to Reduce Radiation Dose in Children With Brain Tumors
• Medulloblastoma subgrouping at first sight
• Melatonin Inhibits Hypoxia-Induced Alzheimer's Disease Pathogenesis by Regulating the Amyloidogenic Pathway in Human Neuroblastoma Cells
• Methylglyoxal induces death in human brain neuronal cells (SH-SY5Y), prevented by metformin and dapagliflozin
• Molecular Characterization and Inhibition of a Novel Stress-Induced Mitochondrial Protecting Role for Misfolded TrkAIII in Human SH-SY5Y Neuroblastoma Cells
• Molecular pathway of anticancer effect of next-generation HSP90 inhibitors XL-888 and Debio0932 in neuroblastoma cell line
• Multiomic profiling of medulloblastoma reveals subtype-specific targetable alterations at the proteome and N-glycan level
• Neuroblastoma-A Review of Combination Immunotherapy
• Neuroblastoma, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology
• Neuroprotection by <em>Anethum graveolens</em> (Dill) Seeds and Its Phytocompounds in SH-SY5Y Neuroblastoma Cell Lines and Acellular Assays
• Neuroprotective Strategies and Cell-Based Biomarkers for Manganese-Induced Toxicity in Human Neuroblastoma (SH-SY5Y) Cells
• Neurosurgical short-term outcomes for pediatric medulloblastoma patients and molecular correlations: a 10-year single-center observation cohort study
• Neurotrophic tyrosine receptor kinase gene fusions in adult and pediatric patients with solid tumors: a clinicogenomic biobank and record linkage study of expression frequency and patient characteristics from Finland
• New Mechanism for the Apoptosis of Human Neuroblastoma Cells by the Interaction between Fluorene-9-Bisphenol and the G Protein-Coupled Estrogen Receptor 1
• Non-C19MC-altered embryonal tumor with multilayered rosettes in a young woman with DICER1 syndrome: case report and review of the literature
• NR1D1-transactivated lncRNA NUTM2A-AS1 promotes chemoresistance and immune evasion in neuroblastoma via inhibiting B7-H3 degradation
• Olfactory neuroblastoma: A rare sinonasal malignancy
• PRDM6 promotes medulloblastoma by repressing chromatin accessibility and altering gene expression
• Preclinical spheroid models identify BMX as a therapeutic target for metastatic MYCN nonamplified neuroblastoma
• Prenyl Pterocarpans from Algerian <em>Bituminaria bituminosa</em> and Their Effects on Neuroblastoma
• Primary Ewing sarcoma/primitive neuroectodermal tumors of the kidney: Case series of eight cases from a single center with follow-up details
• Primary Ewing's sarcoma of the intestine: case report and literature review
• Prognostic significance of migrasomes in neuroblastoma through machine learning and multi-omics
• Proteomics-based identification of biomarkers reflecting endogenous and exogenous exposure to the advanced glycation end product precursor methylglyoxal in SH-SY5Y human neuroblastoma cells
• Radioimaging Presentation of a Primitive Neuroectodermal Tumor of the Lung in a 13-Year-Old Female: A Case Report
• Response to PARP Inhibition in <em>BARD1</em>-Mutated Refractory Neuroblastoma
• REST-dependent downregulation of von Hippel-Lindau tumor suppressor promotes autophagy in SHH-medulloblastoma
• Risk factors, impact and treatment of postoperative lymphatic leakage in children with abdominal neuroblastoma operated on by laparotomy
• Role and mechanism of cysteine and glycine-rich protein 2 in the malignant progression of neuroblastoma
• Secretomic changes of amyloid beta peptides on Alzheimer's disease related proteins in differentiated human SH-SY5Y neuroblastoma cells
• Serum albumin exposure enhances cell invasiveness and paclitaxel resistance in human neuroblastoma cells, with attenuation by valeriana-type iridoid glycosides
• Successful endoscopic approach for peripheral neuroblastic tumors in children
• Surgery for abdominal neuroblastoma in children
• Survival Analysis and Prognostic Factors After Endonasal Resection of Advanced Olfactory Neuroblastomas: A Single Institution Experience
• Survival-Related Genes on Chromosomes 6 and 17 in Medulloblastoma
• Synergistic Effect of Flavonoids and Metformin on Protection of the Methylglyoxal-Induced Damage in PC-12 Neuroblastoma Cells: Structure-Activity Relationship and Potential Target
• Systemic inflammation enhances metastatic growth in a syngeneic neuroblastoma mouse model
• The KAT module of the SAGA complex maintains the oncogenic gene expression program in <em>MYCN-</em>amplified neuroblastoma
• The miR-29 family facilitates the activation of NK-cell immune responses by targeting the B7-H3 immune checkpoint in neuroblastoma
• The Role of the RNA Helicase DDX3X in Medulloblastoma Progression
• The TERT Promoter is Polycomb-Repressed in Neuroblastoma Cells with Long Telomeres
• The transcriptional co-repressor Runx1t1 is essential for MYCN-driven neuroblastoma tumorigenesis
• Thyroid hormone suppresses medulloblastoma progression through promoting terminal differentiation of tumor cells
• Unusual delayed postradiation vasculopathy mimicking tumour in an early adolescent with a remote history of metastatic medulloblastoma
• Urinary cytologic features of primitive neuroectodermal tumor primarily involving the kidney: A case report
• Utility of OLIG2 immunostaining in pediatric brain tumors with embryonal morphology
• Whole-tumoral metabolic heterogeneity in ¹⁸F-FDG PET/CT is a novel prognostic marker for neuroblastoma
• β-Hydroxybutyrate and melatonin suppress maladaptive UPR, excessive autophagy and pyroptosis in Aβ 1-42 and LPS-Induced SH-SY5Y cells